Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)
Original languageEnglish
Pages (from-to)517-527
Number of pages11
JournalBritish Journal of Cancer
Volume122
Issue number4
DOIs
Publication statusPublished - Feb 18 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment'. Together they form a unique fingerprint.

Cite this